Version 2.1.1.0

Abstract

Grant Number:	1R43AI056236-01
PI Name:	STEGE, JUSTIN T.
PI Email:	jstege@diversa.com
PI Title:
Project Title:	Directed Biosynthesis of Avermectin Derivatives

Abstract: DESCRIPTION (provided by applicant): The ultimate goal of this project is to develop a biosynthetic route to produce the insecticide emamectin from the natural product avermectin. Emamectin is a broad spectrum insecticide with low environmental impact that is not widely used due to the high cost of the current chemical production process. A more efficient biosynthetic process would lower the cost of this compound, increasing the use of emamectin as an environmentally compatible alternative to traditional chemical insecticides. Successful development of this process will lead the way to directed design of biosynthetic routes to new and existing natural product derivatives for pharmaceutical, agricultural and other applications. The proposed research project may also generate novel avermectin derivatives with new or altered bioactivities for insecticidal, antiparasitic or other uses.

Thesaurus Terms:
biological product, biosynthesis, chemical synthesis, insect control, insecticide, lactone, technology /technique development
glycosylation, glycosyltransferase, transaminase

Institution:	DIVERSA CORPORATION
	4955 DIRECTORS PL
	SAN DIEGO, CA 921213829
Fiscal Year:	2003
Department:
Project Start:	01-MAY-2003
Project End:	30-APR-2004
ICD:	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
IRG:	ZRG1

---